Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α. | Mol Oncol | 2023 | 37584455 | PubTator, text mining | PubMed |
| The emerging roles of MAPK-AMPK in ferroptosis regulatory network. | Cell Commun Signal | 2023 | 37580745 | PubTator, text mining | PubMed |
| Breast cancers as ecosystems: a metabolic perspective. | Cell Mol Life Sci | 2023 | 37561190 | PubTator, text mining | PubMed |
| Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. | iScience | 2023 | 37554459 | PubTator, text mining | PubMed |
| Reconstruction of the last bacterial common ancestor from 183 pangenomes reveals a versatile ancient core genome. | Genome Biol | 2023 | 37553643 | PubTator, text mining | PubMed |
| Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response. | Nat Metab | 2023 | 37550596 | PubTator, text mining | PubMed |
| Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis. | Cancer Gene Ther | 2023 | 37542132 | PubTator, text mining | PubMed |
| Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer. | Nat Commun | 2023 | 37542037 | PubTator, text mining | PubMed |
| A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer. | Front Oncol | 2023 | 37534256 | PubTator, text mining | PubMed |
| Shared Gene Targets of the ATF4 and p53 Transcriptional Networks. | Mol Cell Biol | 2023 | 37533313 | PubTator, text mining | PubMed |
| NUCKS1, a LINC00629-upregulated gene, facilitated osteosarcoma progression and metastasis by elevating asparagine synthesis. | Cell Death Dis | 2023 | 37528150 | PubTator, text mining | PubMed |
| Divergent Proteome Reactivity Influences Arm-Selective Activation of the Unfolded Protein Response by Pharmacological Endoplasmic Reticulum Proteostasis Regulators. | ACS Chem Biol | 2023 | 37523656 | PubTator, text mining | PubMed |
| From the Discovery of Targets to Delivery Systems: How to Decipher and Improve the Metallodrugs' Actions at a Molecular Level. | Pharmaceutics | 2023 | 37514183 | PubTator, text mining | PubMed |
| A Prognostic Model of Head and Neck Cancer Based on Amino Acid Metabolism-Related Signature and Its Implication for Immunosuppressive Microenvironment. | Int J Mol Sci | 2023 | 37511510 | PubTator, text mining | PubMed |
| Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress. | Int J Mol Sci | 2023 | 37511223 | PubTator, text mining | PubMed |
| Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases. | Children (Basel) | 2023 | 37508657 | PubTator, text mining | PubMed |
| FGFR-mediated ERK1/2 signaling contributes to mesendoderm and definitive endoderm formation in vitro. | iScience | 2023 | 37502260 | PubTator, text mining | PubMed |
| Targeting mutant p53 stabilization for cancer therapy. | Front Pharmacol | 2023 | 37502209 | PubTator, text mining | PubMed |
| Detecting intragenic trans-splicing events from non-co-linearly spliced junctions by hybrid sequencing. | Nucleic Acids Res | 2023 | 37497782 | PubTator, text mining | PubMed |
| Novel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells. | Genes Dis | 2023 | 37492746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=10